Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Booth

Showing results (261-270 of 349) with videos related to

Pageof 35
Sort By:
Journal of Global Oncology|December 16, 2017
Delivery of Global Cancer Care: An International Study of Medical Oncology WorkloadAdam Fundytus, Richard Sullivan, Verna Vanderpuye, et al.
JAMA Internal Medicine|October 18, 2021
Real-world Use of and Spending on New Oral Targeted Cancer Drugs in the US, 2011-2018Mengyuan Fu, Huseyin Naci, Christopher M Booth, et al.
The Oncologist|May 25, 2023
Contact Days Associated With Cancer Treatments in the CCTG LY.12 TrialArjun Gupta, Annette E Hay, Michael Crump, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 13, 2022
The least costly pharmacy for cancer supportive care medications over time: the logistic toxicity of playing catch upAndrew Etteldorf, Ramy Sedhom, Shannon M Rotolo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2021
Long-Term Mental Health Service Utilization Among Survivors of Testicular Cancer: A Population-Based Cohort StudyMichael J Raphael, Sumit Gupta, Xuejiao Wei, et al.
BMJ (Clinical Research Ed.)|September 20, 2019
Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysisHuseyin Naci, Courtney Davis, Jelena Savović, et al.
Journal of the National Cancer Institute|December 16, 2017
Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug AdministrationAriadna Tibau, Consolación Molto, Alberto Ocana, et al.
European Journal of Cancer (Oxford, England : 1990)|November 4, 2023
Quality indicators for systemic anticancer therapy services: a systematic review of metrics used to compare quality across healthcare facilitiesKari Leung, Megan McLeod, Julie Torode, et al.
Annals of Surgical Oncology|March 13, 2022
Incidence, Timing, and Outcomes of Venous Thromboembolism in Patients Undergoing Surgery for Esophagogastric Cancer: A Population-Based Cohort StudyNader M Hanna, Erin Williams, Weidong Kong, et al.
Journal of the National Cancer Institute|March 24, 2021
Application of Value Frameworks to the Design of Clinical Trials: The Canadian Cancer Trials Group ExperienceJoseph C Del Paggio, Adam M Fundytus, Wilma M Hopman, et al.
Pageof 35

Showing results (261-270 of 349) with videos related to

Sort By:
Pageof 35
Journal of Global Oncology|December 16, 2017
Delivery of Global Cancer Care: An International Study of Medical Oncology WorkloadAdam Fundytus, Richard Sullivan, Verna Vanderpuye, et al.
JAMA Internal Medicine|October 18, 2021
Real-world Use of and Spending on New Oral Targeted Cancer Drugs in the US, 2011-2018Mengyuan Fu, Huseyin Naci, Christopher M Booth, et al.
The Oncologist|May 25, 2023
Contact Days Associated With Cancer Treatments in the CCTG LY.12 TrialArjun Gupta, Annette E Hay, Michael Crump, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 13, 2022
The least costly pharmacy for cancer supportive care medications over time: the logistic toxicity of playing catch upAndrew Etteldorf, Ramy Sedhom, Shannon M Rotolo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2021
Long-Term Mental Health Service Utilization Among Survivors of Testicular Cancer: A Population-Based Cohort StudyMichael J Raphael, Sumit Gupta, Xuejiao Wei, et al.
BMJ (Clinical Research Ed.)|September 20, 2019
Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysisHuseyin Naci, Courtney Davis, Jelena Savović, et al.
Journal of the National Cancer Institute|December 16, 2017
Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug AdministrationAriadna Tibau, Consolación Molto, Alberto Ocana, et al.
European Journal of Cancer (Oxford, England : 1990)|November 4, 2023
Quality indicators for systemic anticancer therapy services: a systematic review of metrics used to compare quality across healthcare facilitiesKari Leung, Megan McLeod, Julie Torode, et al.
Annals of Surgical Oncology|March 13, 2022
Incidence, Timing, and Outcomes of Venous Thromboembolism in Patients Undergoing Surgery for Esophagogastric Cancer: A Population-Based Cohort StudyNader M Hanna, Erin Williams, Weidong Kong, et al.
Journal of the National Cancer Institute|March 24, 2021
Application of Value Frameworks to the Design of Clinical Trials: The Canadian Cancer Trials Group ExperienceJoseph C Del Paggio, Adam M Fundytus, Wilma M Hopman, et al.
Pageof 35